KR100567941B1 - (-)시스-3-하이드록시-1-메틸-4-(2,4,6-트리메톡시페닐)-피페리딘의 제조방법 - Google Patents

(-)시스-3-하이드록시-1-메틸-4-(2,4,6-트리메톡시페닐)-피페리딘의 제조방법 Download PDF

Info

Publication number
KR100567941B1
KR100567941B1 KR1020007007959A KR20007007959A KR100567941B1 KR 100567941 B1 KR100567941 B1 KR 100567941B1 KR 1020007007959 A KR1020007007959 A KR 1020007007959A KR 20007007959 A KR20007007959 A KR 20007007959A KR 100567941 B1 KR100567941 B1 KR 100567941B1
Authority
KR
South Korea
Prior art keywords
formula
methyl
trimethoxyphenyl
tetrahydropyridine
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
KR1020007007959A
Other languages
English (en)
Korean (ko)
Other versions
KR20010024867A (ko
Inventor
브라이폴게르하르트
미할로브스키위르겐
Original Assignee
사노피-아벤티스 도이칠란트 게엠베하
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 사노피-아벤티스 도이칠란트 게엠베하 filed Critical 사노피-아벤티스 도이칠란트 게엠베하
Publication of KR20010024867A publication Critical patent/KR20010024867A/ko
Application granted granted Critical
Publication of KR100567941B1 publication Critical patent/KR100567941B1/ko
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/42—Oxygen atoms attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/78—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
KR1020007007959A 1998-01-23 1998-12-18 (-)시스-3-하이드록시-1-메틸-4-(2,4,6-트리메톡시페닐)-피페리딘의 제조방법 Expired - Lifetime KR100567941B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19802449.5 1998-01-23
DE19802449A DE19802449A1 (de) 1998-01-23 1998-01-23 Verfahren zur Herstellung von (-)cis-3-Hydroxy-1-methyl-4-(2,4,6-trimethoxypyhenyl)-piperidin

Publications (2)

Publication Number Publication Date
KR20010024867A KR20010024867A (ko) 2001-03-26
KR100567941B1 true KR100567941B1 (ko) 2006-04-07

Family

ID=7855418

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020007007959A Expired - Lifetime KR100567941B1 (ko) 1998-01-23 1998-12-18 (-)시스-3-하이드록시-1-메틸-4-(2,4,6-트리메톡시페닐)-피페리딘의 제조방법

Country Status (26)

Country Link
US (1) US6225473B1 (https=)
EP (1) EP1049674B1 (https=)
JP (1) JP4585116B2 (https=)
KR (1) KR100567941B1 (https=)
CN (1) CN1137096C (https=)
AR (1) AR015218A1 (https=)
AT (1) ATE355270T1 (https=)
AU (1) AU762407B2 (https=)
BR (1) BR9814774B1 (https=)
CA (1) CA2318946C (https=)
CY (1) CY1106511T1 (https=)
CZ (1) CZ298852B6 (https=)
DE (2) DE19802449A1 (https=)
DK (1) DK1049674T3 (https=)
ES (1) ES2281943T3 (https=)
HU (1) HU227928B1 (https=)
IL (1) IL137422A (https=)
NO (1) NO321933B1 (https=)
NZ (1) NZ505897A (https=)
PL (1) PL190790B1 (https=)
PT (1) PT1049674E (https=)
RU (1) RU2265595C2 (https=)
SK (1) SK285883B6 (https=)
TR (1) TR200002146T2 (https=)
WO (1) WO1999037615A1 (https=)
ZA (1) ZA99477B (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6437136B2 (en) * 1998-01-23 2002-08-20 Aventis Pharma Deutschland Gmbh Process for the preparation of (−)cis-3-hydroxy-1-methyl-4-(2,4,6-trimethoxyphenyl)piperidine
DE19809649A1 (de) * 1998-03-06 1999-09-09 Hoechst Marion Roussel De Gmbh Verfahren zur enzymatischen Enantiomeren-Trennung von 3(R)- und 3(S)-Hydroxy-1-methyl-4-(2,4,6-trimethoxyphenyl)-1,2,3,6-tetrahydro-pyridin bzw. der Carbonsäureester
HK1251655A1 (zh) 2015-04-20 2019-02-01 Tolero Pharmaceuticals, Inc. 通过线粒体分析预测对阿伏西地的应答
KR102608921B1 (ko) 2015-05-18 2023-12-01 스미토모 파마 온콜로지, 인크. 생체 이용률이 증가된 알보시딥 프로드러그
JP7083497B2 (ja) 2015-08-03 2022-06-13 スミトモ ファーマ オンコロジー， インコーポレイテッド がんの処置のための併用療法
WO2018094275A1 (en) 2016-11-18 2018-05-24 Tolero Pharmaceuticals, Inc. Alvocidib prodrugs and their use as protein kinase inhibitors
AU2017379847B2 (en) 2016-12-19 2022-05-26 Sumitomo Pharma Oncology, Inc. Profiling peptides and methods for sensitivity profiling
JP7196160B2 (ja) 2017-09-12 2022-12-26 スミトモ ファーマ オンコロジー， インコーポレイテッド Ｍｃｌ－１阻害剤アルボシジブを用いた、ｂｃｌ－２阻害剤に対して非感受性である癌の治療レジメン
US11034710B2 (en) 2018-12-04 2021-06-15 Sumitomo Dainippon Pharma Oncology, Inc. CDK9 inhibitors and polymorphs thereof for use as agents for treatment of cancer
WO2020191326A1 (en) 2019-03-20 2020-09-24 Sumitomo Dainippon Pharma Oncology, Inc. Treatment of acute myeloid leukemia (aml) with venetoclax failure
CN110577974B (zh) * 2019-09-10 2021-07-20 杭州澳赛诺生物科技有限公司 手性3-羟基-1,2,3,6-四氢吡啶的合成方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN164232B (https=) * 1986-04-11 1989-02-04 Hoechst India
US5284856A (en) * 1988-10-28 1994-02-08 Hoechst Aktiengesellschaft Oncogene-encoded kinases inhibition using 4-H-1-benzopyran-4-one derivatives
DE3836676A1 (de) * 1988-10-28 1990-05-03 Hoechst Ag Die verwendung von 4h-1-benzopyran-4-on-derivaten, neue 4h-1-benzopyran-4-on-derivate und diese enthaltende arzneimittel
US5849733A (en) * 1996-05-10 1998-12-15 Bristol-Myers Squibb Co. 2-thio or 2-oxo flavopiridol analogs
US5908934A (en) 1996-09-26 1999-06-01 Bristol-Myers Squibb Company Process for the preparation of chiral ketone intermediates useful for the preparation of flavopiridol and analogs

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
International Journal of Oncology, vol. 9, pp. 1143-1168(1996) *

Also Published As

Publication number Publication date
RU2265595C2 (ru) 2005-12-10
CZ20002665A3 (cs) 2001-11-14
CA2318946C (en) 2009-11-03
DK1049674T3 (da) 2007-06-25
CN1284065A (zh) 2001-02-14
CZ298852B6 (cs) 2008-02-27
KR20010024867A (ko) 2001-03-26
ATE355270T1 (de) 2006-03-15
NO321933B1 (no) 2006-07-24
CN1137096C (zh) 2004-02-04
NO20003454D0 (no) 2000-07-04
PT1049674E (pt) 2007-04-30
AU762407B2 (en) 2003-06-26
TR200002146T2 (tr) 2000-12-21
IL137422A (en) 2005-11-20
SK10972000A3 (sk) 2000-12-11
BR9814774B1 (pt) 2010-10-05
EP1049674B1 (de) 2007-02-28
JP4585116B2 (ja) 2010-11-24
SK285883B6 (sk) 2007-10-04
ZA99477B (en) 1999-09-23
CY1106511T1 (el) 2012-01-25
US6225473B1 (en) 2001-05-01
NO20003454L (no) 2000-07-04
HUP0100649A1 (hu) 2001-07-30
ES2281943T3 (es) 2007-10-01
NZ505897A (en) 2003-03-28
PL190790B1 (pl) 2006-01-31
AR015218A1 (es) 2001-04-18
HU227928B1 (en) 2012-06-28
DE19802449A1 (de) 1999-07-29
EP1049674A1 (de) 2000-11-08
SK285883B9 (https=) 2007-12-06
JP2002501048A (ja) 2002-01-15
HK1033319A1 (en) 2001-08-24
WO1999037615A1 (de) 1999-07-29
CA2318946A1 (en) 1999-07-29
DE59813924D1 (de) 2007-04-12
AU2513599A (en) 1999-08-09
IL137422A0 (en) 2001-07-24
BR9814774A (pt) 2000-11-14
HUP0100649A3 (en) 2002-12-28
PL342064A1 (en) 2001-05-21

Similar Documents

Publication Publication Date Title
US5886171A (en) 3-hydroxy gamma-lactone based enantioselective synthesis of azetidinones
EP0906278B1 (en) 3-hydroxy gamma-lactone based enantioselective synthesis of azetidinones
KR100567941B1 (ko) (-)시스-3-하이드록시-1-메틸-4-(2,4,6-트리메톡시페닐)-피페리딘의 제조방법
CA2279960C (en) Synthesis of terfenadine and derivatives
US6437136B2 (en) Process for the preparation of (−)cis-3-hydroxy-1-methyl-4-(2,4,6-trimethoxyphenyl)piperidine
WO2000026187A1 (en) Process for producing 4-arylpiperidine-3-carbinols and related compounds
KR20010102366A (ko) 파록세틴의 제조방법
US4769480A (en) Benzylamine derivative
MXPA00006631A (en) Method for producing (-)cis-3-hydroxy-1-methyl-4- (2,4,6-trimethoxyphenyl)-piperidine
JPH10114743A (ja) １−アシル−４−アリールピペリジン類の製造方法
CN121045061A (zh) 一种n,n'-双-(2,2,6,6-四甲基-4-哌啶基)-1,6-己二胺的合成方法
JP2000515534A (ja) ３，３―二置換ピペリジンの製造方法
US20020010155A1 (en) Novel process
EP1140832A1 (en) Process for preparing arylpiperidine carbinol intermediates and derivatives
KR20010013102A (ko) 신규한 방법
HK1033319B (en) Method for producing (-)cis-3-hydroxy-1-methyl-4-(2,4,6-trimethoxy-phenyl)-piperidine
JP2006199600A (ja) アルコキシピペリジン誘導体の製造法

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20000720

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20031212

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20050830

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20060110

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20060330

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20060331

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20090326

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 20100323

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 20110217

Start annual number: 6

End annual number: 6

PR1001 Payment of annual fee

Payment date: 20120305

Start annual number: 7

End annual number: 7

FPAY Annual fee payment

Payment date: 20130305

Year of fee payment: 8

PR1001 Payment of annual fee

Payment date: 20130305

Start annual number: 8

End annual number: 8

FPAY Annual fee payment

Payment date: 20140312

Year of fee payment: 9

PR1001 Payment of annual fee

Payment date: 20140312

Start annual number: 9

End annual number: 9

FPAY Annual fee payment

Payment date: 20160311

Year of fee payment: 11

PR1001 Payment of annual fee

Payment date: 20160311

Start annual number: 11

End annual number: 11

FPAY Annual fee payment

Payment date: 20170320

Year of fee payment: 12

PR1001 Payment of annual fee

Payment date: 20170320

Start annual number: 12

End annual number: 12

FPAY Annual fee payment

Payment date: 20180312

Year of fee payment: 13

PR1001 Payment of annual fee

Payment date: 20180312

Start annual number: 13

End annual number: 13

EXPY Expiration of term
PC1801 Expiration of term

Termination date: 20190618

Termination category: Expiration of duration